Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
A study of TRV045 to test its effects on brain cell electrical activity in healthy adult men for epilepsy treatment development
The NetherlandsA study to assess how SAR443820 is absorbed, broken down and removed by the body in healthy adult men
The NetherlandsA study testing TRV045 for pain relief in healthy adults to understand its effects on nerve pain from diabetic peripheral neuropathy
The NetherlandsStudy of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk
BelgiumA study of immune system response in adults who develop shingles after receiving recombinant herpes zoster vaccine to understand vaccine protection
BelgiumA study testing the safety and how the body processes TAK-861 in children and teenagers aged 6 to 17 years with narcolepsy type 1
ItalyA Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease
FinlandA Study to Evaluate the Safety of Olipudase Alfa in Children and Adults with Niemann-Pick Disease Who Completed Previous Treatment Studies
FranceStudy of Cromolyn Inhalation Treatment for Patients with Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)
CzechiaStudy of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson's disease and motor fluctuations
ItalyStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
AustriaStudy of RO7126209 safety and effects given by intravenous infusion in patients with early stage or mild to moderate Alzheimer's disease
PolandThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
